| Synonyms: | |
| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| UNII: | SY7Q814VUP |
| Parent Compound: | CALCIUM |
Structure
| InChI Key | FAQLAUHZSGTTLN-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | H2Ca |
| Molecular Weight | 42.09 |
| AlogP | None |
| Hydrogen Bond Acceptor | None |
| Hydrogen Bond Donor | None |
| Number of Rotational Bond | None |
| Polar Surface Area | None |
| Molecular species | None |
| Aromatic Rings | None |
| Heavy Atoms | None |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Polycystic Ovary Syndrome | 3 | D011085 | ClinicalTrials |
| Arthritis, Juvenile | 3 | D001171 | ClinicalTrials |
| Fractures, Bone | 3 | D050723 | ClinicalTrials |
| Hip Fractures | 3 | D006620 | ClinicalTrials |
| Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
| Osteitis Deformans | 3 | D010001 | ClinicalTrials |
| Hyperprolactinemia | 3 | D006966 | ClinicalTrials |
| Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
| Bone Diseases, Metabolic | 3 | D001851 | ClinicalTrials |
| Hypocalcemia | 3 | D006996 | ClinicalTrials |
| Ovarian Hyperstimulation Syndrome | 3 | D016471 | ClinicalTrials |
| Menopause | 3 | D008593 | ClinicalTrials |
| Colonic Neoplasms | 3 | D003110 | ClinicalTrials |
| Myocardial Ischemia | 3 | D017202 | ClinicalTrials |
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 3 | D064129 | ClinicalTrials |
| Pain | 3 | D010146 | ClinicalTrials |
| Adenoma | 3 | D000236 | ClinicalTrials |
| Osteoporosis, Postmenopausal | 3 | D015663 | ClinicalTrials |
| Osteoporosis | 3 | D010024 | ClinicalTrials |
| Hypertension | 3 | D006973 | ClinicalTrials |
| Obesity | 3 | D009765 | ClinicalTrials |
| Leukemia | 3 | D007938 | ClinicalTrials |
| Lymphoma | 3 | D008223 | ClinicalTrials |
| Heart Diseases | 2 | D006331 | ClinicalTrials |
| Hypersensitivity | 2 | D006967 | ClinicalTrials |
| Pre-Eclampsia | 2 | D011225 | ClinicalTrials |
| Hypoparathyroidism | 2 | D007011 | ClinicalTrials |
| Parkinson Disease | 2 | D010300 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Giant Cell Tumors | 2 | D005870 | ClinicalTrials |
| Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
| Heart Failure | 2 | D006333 | ClinicalTrials |
| Giant Cell Tumor of Bone | 2 | D018212 | ClinicalTrials |
| Hyperparathyroidism, Primary | 2 | D049950 | ClinicalTrials |
| Vitamin D Deficiency | 1 | D014808 | ClinicalTrials |
| Dental Caries | 1 | D003731 | ClinicalTrials |
| Renal Insufficiency, Chronic | 1 | D051436 | ClinicalTrials |
| Osteogenesis Imperfecta | 1 | D010013 | ClinicalTrials |
| HIV Infections | 0 | D015658 | ClinicalTrials |
| Wounds and Injuries | 0 | D014947 | ClinicalTrials |
Related Entries
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 7440-70-2 |
| ChEMBL | CHEMBL2146121 |
| EPA CompTox | DTXSID9050484 |
| FDA SRS | SY7Q814VUP |
| PubChem | 5460341 |
| SureChEMBL | SCHEMBL5560130 |
CONTENTS